BDBM435135 4-(1-(2-chloro-6-(1- (difluoromethyl)cyclo- propyl)benzoyl)-1H- pyrazolo[4,3- b]pyridin-3-yl)-3- fluorobenzoic acid::US10584121, Example 1D

SMILES OC(=O)c1ccc(-c2nn(C(=O)c3c(Cl)cccc3C3(CC3)C(F)F)c3cccnc23)c(F)c1

InChI Key InChIKey=RJVYRMTUJPWUAY-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 435135   

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM435135(US10584121, Example 1D | 4-(1-(2-chloro-6-(1- (dif...)
Affinity DataIC50: 1.40nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent